Pharmaceutical Industry
GMP-compliant reactors for API synthesis, intermediates, and sterile processes
Pharmaceutical manufacturing demands what standard reactors can't deliver: surface finish controlled to 0.4μm Ra, full material traceability, and documentation that passes FDA and EMA audits. We build reactors designed for your process conditions and your regulatory requirements — not a catalog default.
Industry Challenges
Multi-product facilities need reactors that clean thoroughly between batches. Poor surface finish or dead zones harbor residues that standard reactors miss.
Material certificates missing, NDT reports incomplete, or nameplate data inconsistent — these are audit findings that delay product release.
CIP systems fail when agitator design creates shadow zones. A reactor that looks clean isn't clean enough for pharma.
Our Approach
Interior polished to your specification — 0.4μm Ra for sterile products, 0.8μm for intermediates. Every surface is mapped; no blind spots.
MTR for every plate, forging, and welding consumable. NDT reports (RT/UT/PT/MT) with weld map. Nameplate matches the reactor exactly.
Agitator geometry selected to eliminate dead zones. No dead angles in the vessel. Spray ball coverage validated against your cleaning protocol.
Typical Specifications
| Parameter | Specification |
|---|---|
| Volume Range | 100L – 50,000L |
| Materials | 316L, 304L, Duplex, Hastelloy |
| Surface Finish | 0.4–1.0 μm Ra (interior) |
| Design Pressure | Up to 20 MPa |
| Certifications | ASME VIII, GB150, PED |
| Seal Type | Magnetic coupling (zero leakage) |
Related Products
Related Cases
Tell us your medium, temperature, pressure, and volume requirements. We'll recommend the right reactor design and material within 24 hours.